Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis:: A double-blind, double-dummy, randomized, controlled, dose-ranging study

被引：0
|
作者：
Kruis, Wolfgang
Jonaitis, Laimas
Pokrotnieks, Juris
Acute, Gitana
Mikhailova, Tatyana L.
Horynski, Marek
Batovsky, Marian
Racz, Istvan
Kull, Karin
Faszczyk, Mark
Greinwald, Roland
Mueller, Ralph
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A489 / A489
页数：1
相关论文
共 50 条
  • [41] A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia
    Marberger, Michael
    Chartier-Kastler, Emmanuel
    Egerdie, Blair
    Lee, Kyu-Sung
    Grosse, Joachim
    Bugarin, Denise
    Zhou, Jihao
    Patel, Anand
    Haag-Molkenteller, Cornelia
    EUROPEAN UROLOGY, 2013, 63 (03) : 496 - 503
  • [42] Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study
    Baker, R
    Jasinski, M
    Maciag-Tymecka, I
    Michalowska-Mrozek, J
    Bonikowski, M
    Carr, L
    MacLean, J
    Lin, JP
    Lynch, B
    Theologis, T
    Wendorff, J
    Eunson, P
    Cosgrove, A
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (10) : 666 - 675
  • [43] Efficacy and safety of LY2951742 in a randomized, double-blind, placebo-controlled, dose-ranging study in patients with migraine
    Oakes, T.
    Zhang, Q.
    Ferguson, M.
    Skljarevski, V
    Martinez, J. M.
    Johnson, K. W.
    Schacht, A. L.
    Due, M. R.
    Goadsby, P.
    Dodick, D. W.
    HEADACHE, 2016, 56 : 68 - 68
  • [44] Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, double-blind, placebo-controlled study
    Sandborn, WJ
    Stenson, WF
    Brynskov, J
    Steidle, G
    Robbins, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) : S257 - S258
  • [45] A multi-center, double-blind, placebo-controlled, dose-ranging trial of olsalazine for mild-moderately active ulcerative colitis.
    Hanauer, SB
    Barish, C
    Pambianco, D
    Sigmon, R
    Gannan, R
    Koval, G
    Ma, T
    Lamet, M
    Feld, M
    Pruitt, R
    Kogut, D
    Makrauer, F
    Schinagl, E
    GASTROENTEROLOGY, 1996, 110 (04) : A921 - A921
  • [46] Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
    Danese, Silvio
    Colombel, Jean-Frederic
    Lukas, Milan
    Gisbert, Javier P.
    D'Haens, Geert
    Hayee, Bu'hussain
    Panaccione, Remo
    Kim, Hyun-Soo
    Reinisch, Walter
    Tyrrell, Helen
    Oh, Young S.
    Tole, Swati
    Chai, Akiko
    Chamberlain-James, Kirsten
    Tang, Meina Tao
    Schreiber, Stefan
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 118 - 127
  • [47] EFFICACY AND SAFETY OF LY2951742 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY IN PATIENTS WITH MIGRAINE
    Skljarevski, V.
    Oakes, T.
    Ferguson, M.
    Zhang, Q.
    Martinez, J.
    Johnson, K.
    Schacht, A.
    Due, M.
    Goadsby, P.
    Dodick, D.
    CEPHALALGIA, 2016, 36 : 42 - 42
  • [48] Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study
    Bachert, C
    Chuchalin, AG
    Eisebitt, R
    Netayzhenko, VZ
    Voelker, M
    CLINICAL THERAPEUTICS, 2005, 27 (07) : 993 - 1003
  • [49] Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis A Randomized Double-Blind Placebo-controlled Pilot Study
    Banerjee, Rupa
    Pal, Partha
    Penmetsa, Amulya
    Kathi, Pradip
    Girish, Ganesh
    Goren, Idan
    Reddy, D. Nageshwar
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (08) : 702 - 708
  • [50] EARLY RESULTS OF A RANDOMIZED, DOUBLE-BLIND DOSE-RANGING STUDY OF IV STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION
    SIX, AJ
    LOUWERENBURG, JW
    BRAAMS, R
    MOSTERD, WL
    BREDERO, AC
    KERKKAMP, HJ
    BROMMER, EJP
    VANHEMEL, NM
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 58 - 58
12345